Phase II study of VR647 for Asthma in children

Trial Profile

Phase II study of VR647 for Asthma in children

Recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Mar 2018

At a glance

  • Drugs Budesonide (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Mar 2018 According to a Vectura media release, the study is expected to be complete in Q3 2018.
    • 04 Jan 2018 According to a Vectura media release, first patient has been dosed in December 2017 and activities are expected to complete in mid-2018.
    • 04 Jan 2018 Status changed from planning to recruiting according to Vectura media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top